Jul 3Therapy Shows Promise for Rare Leukemia in ChildrenKinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for an aggressive form of blood cancer in small children.Read more: https://www.aacr.org/patients-caregivers/progress-against-cancer/therapy-shows-promise-for-rare-leukemia-in-children/
Kinase inhibitor trametinib may spare patients from intensive treatments, such as stem cell transplant, for an aggressive form of blood cancer in small children.Read more: https://www.aacr.org/patients-caregivers/progress-against-cancer/therapy-shows-promise-for-rare-leukemia-in-children/
Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia
Commentaires